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Evaluating Gene Drive Approaches
for Public Benefit
Michael R. Santos

Abstract Gene drive approaches—those which bias inheritance of a genetic element in a population of sexually reproducing organisms—have the potential to provide important public benefits. The spread of selected genetic elements in wild
populations of organisms may help address certain challenges, such as transmission
of vector-borne human and animal diseases and biodiversity loss due to invasive
animals. Adapting various naturally occurring gene drive mechanisms to these aims
is a long-standing research area, and recent advances in genetics have made engineering gene drive systems significantly more technically feasible. Gene drive
approaches would act through changes in natural environments, thus robust methods to evaluate potential research and use are important.
Despite the fact that gene drive approaches build on existing paradigms, such as
genetic modification of organisms and conventional biological control, there are
material challenges to their evaluation. One challenge is the inherent complexity of
ecosystems, which makes precise prediction of changes to the environment difficult. For gene drive approaches that are expected to spread spatially and/or persist
temporally, responding to this difficulty with the typical stepwise increases in the
scale of studies may not be straightforward after studies begin in the natural environment. A related challenge is that study or use of a gene drive approach may have
implications for communities beyond the location of introduction, depending on the
spatial spread and persistence of the approach and the population biology of the
target organism. This poses a particular governance challenge when spread across
national borders is plausible. Finally, community engagement is an important element of responsible research and governance, but effective community engagement
for gene drive approaches requires addressing complexity and uncertainty and supporting representative participation in decision making.
These challenges are not confronted in a void. Existing frameworks, processes,
and institutions provide a basis for effective evaluation of gene drive approaches for
public benefit. Although engineered gene drive approaches are relatively new, the
necessities of making decisions despite uncertainty and governing actions with
potential implications for shared environments are well established. There are methodologies to identify potential harms and assess risks when there is limited
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e xperience to draw upon, and these methodologies have been applied in similar
contexts. There are also laws, policies, treaties, agreements, and institutions in place
across many jurisdictions that support national and international decision making
regarding genetically modified organisms and the potential applications of gene
drive approaches, such as public health and biodiversity conservation. Community
engagement is an established component of many decision-making processes, and
related experience and conceptual frameworks can inform engagement by
researchers.
The existence of frameworks, processes, and institutions provides an important
foundation for evaluating gene drive approaches, but it is not sufficient by itself.
They must be rigorously applied, which requires resources for risk assessment,
research, and community engagement and diligent implementation by governance
institutions. The continued evolution of the frameworks, processes, and institutions
is important to adapt to the growing understanding of gene drive approaches. With
appropriate resources and diligence, it will be possible to responsibly evaluate and
make decisions on gene drive approaches for public benefit.
Keywords Gene drive · Risk assessment · Governance · Community engagement ·
Biosafety · Public benefit · Decision making · Uncertainty

 ene Drive Approaches: Potential to Provide Important
G
Public Benefits
Gene drive is a phenomenon of biased inheritance in which the prevalence of a
genetic element is increased, even in the presence of some fitness cost, leading to
the preferential increase of a specific genotype that may determine a specific phenotype from one generation to the next and potentially throughout a population
(National Academies of Sciences, Engineering, and Medicine (NASEM) 2016).
Gene drive is a natural phenomenon observed in populations of many different
organisms; there are multiple natural mechanisms that lead to gene drive, and the
phenomenon has been described with various names (Burt and Trivers 2006). An
important property of gene drive is that the genetic element that increases in frequency in the population can decrease individual fitness compared to a context
without the driving genetic element. Normally a genetic element conveying a fitness
cost would be selected against over time, because offspring that do not inherit the
element will outcompete those that do. However, under some circumstances, the
drive effect can outweigh a fitness cost (e.g., Burt 2003). This property of gene drive
has long been recognized as potentially enabling applications that spread traits in
wild populations of organisms, even if the trait does not convey a fitness advantage
(e.g., Craig et al. 1960; Von Borstel and Buzzati-Traverso 1962; Curtis 1968).
The features of gene drive enable potential applications of gene drive approaches
for public benefit (e.g., Esvelt et al. 2014; NASEM 2016; Australian Academy of
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Science 2017). The contexts where gene drive approaches may be most applicable
are those where the organism of interest reproduces sexually with a short generation
time (compared to timescales of interest) and there is well-mixed mating across the
relevant populations (e.g., Burt 2003; Esvelt et al. 2014). There is long-standing
interest in gene drive approaches to reducing transmission of vector-borne human
and animal diseases (e.g., Serebrovsky 1940; Craig et al. 1960; Curtis 1968; Ribeiro
and Kidwell 1994; Burt 2003, 2014). Given the success of vector control in reducing the burden of vector-borne diseases (e.g., vector control interventions accounted
for 78% of the reduction in malaria prevalence from 2000 to 2015; Bhatt et al.
2015), complementary gene drive approaches may be transformational tools to
eliminate or eradicate vector-borne disease (NASEM 2016; NEPAD and the African
Union 2018). There is also current interest in biodiversity preservation (e.g., through
population reduction of invasive species or increased resilience for endangered species; Redford et al. 2019), agricultural pest control (e.g., Scott et al. 2018), and crop
resilience (e.g., Pixley et al. 2019). Gene drive approaches can be particularly well
suited to public benefit because their benefits would accrue to everyone in the
area of use.
Gene drive approaches may provide a useful complement to other approaches to
important public goals and should be considered in that context. The potential applications of gene drive approaches are pursued through a variety of means currently,
such as insecticides/pesticides/rodenticides, conventional removal of invasive species, conventional biocontrol, breeding programs, and genetic modification (e.g.,
NASEM 2016). In many cases existing interventions are insufficient or undesirable
(e.g., Feachem et al. 2019, for the case of malaria eradication, where cost and widespread insecticide resistance limit the impact of current tools, and Campbell et al.
2015, for the case of invasive rodents, where cost and toxicity limit the impact of
toxicants). Gene drive approaches may complement existing interventions by being
lower cost (because of potential spread and persistence) and species specific in their
direct effect. As discussed above, gene drive approaches may also promote equity
because their benefits accrue to the areas in which they are used, rather than to individuals, and thus do not depend on individual resources such as wealth and time;
inequity may still exist between areas that have access to gene drive approaches and
those that do not.
Given the potential for gene drive approaches to provide public benefit, there has
been research into adapting or recapitulating a variety of natural gene drive mechanisms in organisms of interest, such as disease vectors. This research resulted in
important advances, such as the first implementation of gene drive in a malaria vector (Windbichler et al. 2011), and has accelerated dramatically since 2015 due to the
application of improved genome editing tools, such as CRISPR-Cas-based tools, to
engineering gene drive (e.g., Dicarlo et al. 2015; Gantz and Bier 2015). There have
been notable successes in laboratory cage experiments with malaria vectors, demonstrating proof of principle of genes that reduce the population of vectors
(Hammond et al. 2016) and reduce mosquitoes’ ability to transmit the parasites that
cause malaria (Gantz et al. 2015). Although resistance to the gene drive mechanism
may be expected over time (e.g., Burt 2003), different drive mechanisms may be
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more or less susceptible to the development of resistance, and techniques have been
identified to delay its development (e.g., Burt 2003; Esvelt et al. 2014; Hammond
et al. 2017; Kyrou et al. 2018; Champer et al. 2018); in addition, gene drive
approaches will often not need to operate indefinitely to deliver their public benefit.
Despite these many technical advances, gene drive is still a difficult phenomenon to
engineer: highly efficient gene drive has been reported in only a handful of organisms and has been difficult to implement even in well-studied animals like mice
(e.g., Grunwald et al. 2019; see also Godwin et al. 2019 and Yosef et al. 2019). To
date, research into genetically engineering gene drive approaches has occurred
exclusively in laboratory containment, and no genetically engineered gene drives
have been introduced into the natural environment.
The advances in genome editing tools are generally expected to enable demonstrations of more varieties of gene drive. Among the principal areas of research are
efforts to engineer control over the spatial spread and temporal persistence of the
driving genetic element. Possible approaches include systems where the drive
mechanism functions only when present above a threshold (e.g., Akbari et al. 2013;
Oberhofer et al. 2019), which tends to limit the spatial spread of the genetic element, and generational limits on the persistence of the gene drive mechanism (e.g.,
Noble et al. 2019), after which natural selection will remove genes with fitness costs
from the population. Another potential method for limiting spread is using a drive
mechanism that operates on a specific genetic sequence that is prevalent only in a
restricted subpopulation (e.g., Sudweeks et al. 2019). In addition to engineering a
priori control into gene drive approaches, there is active research on methods to stop
the spread of a driving genetic element (e.g., Esvelt et al. 2014; Vella et al. 2017;
Basgall et al. 2018; Roggenkamp et al. 2018).
Given the potential for gene drive approaches to contribute to important social
priorities like human and animal health and biodiversity, and the technical progress
in engineering them, the potential challenges associated with gene drive approaches
for public benefit have become a topic of serious consideration for stakeholders (e.g.,
NEPAD and the African Union 2018; Redford et al. 2019). Gene drive approaches
have similar challenges to other activities that make changes to the natural environment, such as establishing a nature reserve or building a hydroelectric dam: ecosystems are complex and the consequences of interventions are difficult to predict with
precision, the environment is spatially interlinked (naturally and through humanassisted transportation) so some local interventions can have effects beyond the location of intervention, and within the affected areas it is not possible for individuals to
personally opt in or opt out of the effects (e.g., National Research Council 2005).
The following sections discuss the challenges of evaluating gene drive approaches
for public benefit and methods for addressing them. There is an increasing diversity
of potential applications and technical strategies for gene drive approaches with a
wide spectrum of possible properties; thus it is not possible to evaluate them as one
group (NASEM 2016). The subsequent sections highlight concepts and methods that
may have applicability in case-by-case evaluation of specific gene drive approaches.
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 hallenges of Evaluating Gene Drive Approaches
C
for Public Benefit
Decision-Making Context
The decision-making contexts within which gene drive approaches are evaluated are
important to understanding the challenges. Because the public benefit use cases
generally concern impact on communities and the shared environment, there are
structures already in place for making decisions related to those goals, such as ministries of health responsible for infectious disease control and ministries of environment responsible for endangered species preservation and biodiversity. In addition,
gene drive approaches, depending on their specifics, may be subject to biosafety
regulations, policies, and laws, implemented by national biosafety authorities. For
gene drive approaches where the responsibilities of multiple regulatory and policy
interests intersect, effective integration can be difficult (e.g., NASEM 2017).
The governance of decisions on gene drive approaches—the decision-making and
accountability mechanisms—includes laws and treaties as well as “soft law” tools
such as guidelines, recommendations, and norms (NASEM 2016). Researchers and
their institutions play a governance role through their own ethical considerations
(often represented for institutions by institutional review boards or independent ethics committees) and peer- and funder-imposed norms (e.g., Akbari et al. 2015;
Emerson et al. 2017). The responsibility to decide on the use of gene drive approaches
is principally within governments, typically at the national level but potentially also
at sub-national levels, and among governments through international treaties and
agreements such as the Cartagena Protocol on Biosafety to the Convention on
Biological Diversity [CBD] (Secretariat of the CBD 2000). Governance processes at
all levels are generally organized for case-by-case evaluations.
There is a continuum of decisions required for potential research and use of gene
drive approaches (NASEM 2016). For research, the common process is that
researchers propose activities that, where necessary, are externally evaluated.
Laboratory studies of gene drive approaches within containment are typically subject to biosafety review (e.g., UC San Diego Institutional Biosafety Program 2018).
Governance becomes stricter as the likelihood and magnitude of potential undesirable outcomes of a decision (“harms”) are judged to increase; for example, the
Cartagena Protocol on Biosafety includes requirements that apply to the introduction of living modified organisms into the environment that do not apply to contained use (Secretariat of the CBD 2000; see, e.g., Maiga 2018 for the authorization
of a field study of a living modified organism without a gene drive approach).
Decisions regarding use, meaning introduction with direct public benefit as the primary goal, encompass potentially separate decisions about what uses are permitted
(regulatory authorization decisions), what uses are actually implemented (policy
and financing decisions), and what the responsibilities are for harms that are a consequence of use (liability decisions). For example, biosafety regulators and ministries of environment may be responsible for determining under which circumstances,
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if any, gene drive approaches to reducing malaria transmission are allowed; ministries of health and national malaria control programs may be responsible for deciding if and where gene drive approaches will be funded and delivered; and national
laws and international treaties may establish liability associated with potential harm
due to use of the approach (James et al. 2018).
The essential considerations for decision making on gene drive approaches for
public benefit are evaluations of potential benefits, costs, and harms and their likelihoods (NASEM 2016); these considerations are elements of processes like cost-
benefit analyses. Benefits, costs, and harms are subjective evaluations that depend
on values, which differ among individuals and organizations (National Research
Council 2005). As highlighted above, there may be multiple organizations with
responsibility for authorization of a specific gene drive approach; these organizations will have different statutory responsibilities that influence the scope, scale, and
weights of potential benefits, costs, and harms they consider in their evaluations
(e.g., NASEM 2017). These evaluations will typically share a common objective: to
establish potential outcomes associated with proposed research or use of gene drive
approaches and consider the likelihoods of those outcomes.

Uncertainty of Potential Benefits, Costs, and Harms
A significant challenge for the evaluation of gene drive approaches is uncertainty in
the likelihoods of potential benefits, costs, and harms: ecosystems are generally
complex and there is limited experience with gene drive approaches (NASEM
2016). The challenge of uncertainty is not specific to gene drive approaches or biotechnology: large uncertainties are common in the evaluation of many environmental changes, such as fisheries management (e.g., Schwaab 2014), road construction
(e.g., Zhao et al. 2004), use of conventional biocontrol organisms (e.g., Benjamin
and Wesseler 2016), conservation to protect endangered species (e.g., Nicholson
and Possingham 2007), conventional removal of invasive species (e.g., Kessler
2011), and reintroduction of extirpated native species (e.g., Carroll et al. 2019). In
contexts of high uncertainty, particularly regarding potential harms, phased testing
paradigms use stepwise increases in the scale of studies to balance reduction of
uncertainty, exposure to potential harms, and speed of evaluation. For example, the
scale of studies for a gene drive approach might progress successively from physical
containment to semi-field studies under outdoor confinement, small-scale open field
studies, and, finally, larger-scale introductions (NASEM 2016). Each step provides
a higher-fidelity representation of real-world use, thus further reducing uncertainty
about the expected outcomes of use, but also increases the potential exposure to
harms. Thus after each step the accumulated evidence informs the decision on
whether to proceed to the next step; the intensity of governance also typically
increases through the stepwise process.
There may be limitations to the application of the phased testing paradigm to
some gene drive approaches. The paradigm is applicable for the earlier phases of
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research, within physical confinement. However, some gene drive approaches would
be expected to spatially spread and temporally persist after the first introduction to
the natural environment, even if that introduction were in the context of a field trial.
Even when gene drive approaches include mechanisms to control spread and/or persistence, the efficacies of those control mechanisms won’t be known until they are
tested in the field. For these reasons, field trials of some gene drive approaches may
be evaluated similarly to decisions about small-scale introductions, where a greater
degree of environmental exposure is assumed (e.g., James et al. 2018).
The ability to detect incipient harms and respond to, eliminate, or reduce them is
an important component of the evaluation of potential harms of gene drive
approaches; this ability is likely to vary substantially across specific cases of gene
drive approaches (NASEM 2016). In general, the complexity of ecosystems may
make it difficult to determine whether any changes in the environment that happen
after the introduction of a gene drive approach were caused by the gene drive
approach. The potential for some gene drive approaches to spread and persist from
relatively low prevalence in a population may present an obstacle to circumscribing
the location where risk response is necessary, even when an effective conventional
response (e.g., conventional vector control or invasive species removal) is available.
Gene drive approaches designed to stop the effects of a previously introduced gene
drive may have particular advantages for removing an undesired gene drive approach
from the environment (e.g., Vella et al. 2017), but with the associated uncertainty of
introducing another gene drive approach.

Potential Spread and Persistence
The potential spatial spread and temporal persistence of some gene drive approaches
create another important challenge. Depending on the scale of introduction, population biology of the target species, and specifics of the approach, communities
beyond the location of introduction of a gene drive approach may be affected (e.g.,
Marshall 2009). Which communities will be affected, and when, will depend on
properties of the gene drive approach and natural environment (e.g., North
et al. 2019).
As a consequence, decision makers such as regulators could be asked to evaluate gene drive approaches expected to spread outside of their jurisdictions, including across national borders (e.g., Brown 2017). Policymakers will need to consider
the legal and political implications of the potential spread of gene drive approaches;
in particular, the spread of genetically modified organisms across international
borders is regulated under the Cartagena Protocol on Biosafety (for countries that
are signatories; Secretariat of the CBD 2000). Legal risks associated with liability
and redress will be particularly consequential for decisions about potential implementation of approved gene drive approaches (e.g., Oye et al. 2014; Glover
et al. 2018).
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Community Engagement
Consultation with stakeholders, in particular with communities where research or
use of gene drive approaches is being considered, is an important element of the
evaluation of gene drive approaches (e.g., NASEM 2016). For researchers, engagement with affected communities is an ethical obligation (e.g., King et al. 2014). This
responsibility includes providing transparency into the research being conducted, so
that concerns can be identified and addressed, and obtaining community acceptance
of the research (e.g., World Health Organization 2014). In addition, community
engagement by researchers creates an opportunity for co-development of innovation, where community input is expected to improve the quality of the research (e.g.,
NEPAD and the African Union 2018; Hartley et al. 2019). For other decision makers, such as regulators, policymakers, and implementers, community engagement is
commonly an element of their decision-making process (e.g., Quinlan et al. 2016).
For example, many environmental regulators include opportunity for public comment on their pending decisions, local policymakers often convene meetings of their
constituents to address questions and concerns, and international governance institutions like the Convention on Biological Diversity commonly invite online comments on topics under consideration.
There are likely to be multiple elements to the challenge of successful community engagement in decision making (e.g., Kaebnick et al. 2014; Quinlan
et al. 2016; NASEM 2016). Because of the potential uncertainties in spatial
spread and temporal persistence of gene drive approaches, it may not be known
exactly what areas and communities will be affected and when (e.g., Baltzegar
et al. 2018). Communicating effectively given the scientific complexity and
uncertainty of gene drive approaches may also be difficult (e.g., Brossard et al.
2019). Gene drive approaches will have area-wide effects that, like existing
community interventions, do not allow for opting in or opting out at the level of
the individual (e.g., Thizy et al. 2019); elements of research, such as social science research or access to private property, may still require individual consent
(e.g., Kolopack and Lavery 2017). Governments routinely make decisions for
communities, though the degree and mechanism for representation and participation vary; for research, community acceptance is less well defined than individual consent, and achieving representative perspectives from communities
can be difficult (e.g., Kaebnick et al. 2014; Thizy et al. 2019). Given that the
elements of the challenge of community engagement will vary with each individual consideration of a gene drive approach, similar to risk assessment there
is unlikely to be a single prescriptive process appropriate for all gene drive
approaches (e.g., Rask and Worthington 2015; NASEM 2016).
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Conclusion
Effective evaluation of gene drive approaches for public benefit depends on these
challenges being successfully addressed. The next section discusses the groundwork that is already in place and additional efforts required to accomplish this.

 ddressing the Challenges of Evaluating Gene Drive
A
Approaches for Public Benefit
The previous section highlighted three important challenges for evaluating gene
drive approaches for public benefit. The first is that the expected environmental,
social, and economic effects of the introduction of a gene drive approach will have
uncertainties, a consequence of the inherent complexity of ecosystems and societies
and limited experience with gene drive approaches. The second is that research or
use of a gene drive approach may affect areas beyond the location of introduction,
including potentially in other countries. The third is that community engagement by
researchers and other decision makers is important but not straightforward. These
challenges are common to other decisions about the shared environment, and thus
there are existing frameworks, processes, and institutions that can help address them.

Managing Uncertainty in Decision Making
Uncertainty is a common challenge in decision making, and there are frameworks
to help characterize and reduce uncertainty (e.g., Aven et al. 2014). Risk assessment, a set of methods to identify and analyze potential outcomes of decisions (e.g.,
Rausand 2011), is one of those frameworks and is recognized as important to the
evaluation of gene drive approaches (e.g., NASEM 2016; Secretariat of the CBD
2000). Risk assessment is a general and flexible framework that can identify potential harms and characterize their likelihood. Risk assessment methods can address
potential health, social, cultural, economic, and environmental harms. The potential
harms considered in any individual risk assessment will depend on the organization
performing it. For example, when regulators perform risk assessments, the scope of
potential harms considered is typically prescribed by laws and policies. Some decisions about gene drive approaches, such as policies about their use, are likely to be
informed by risk assessments considering different categories of potential harms.
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The first step in risk assessment is identification of potential harms within the
scope that is being considered. Identifying harms can incorporate analogous prior
experience (e.g., through checklists of previously experienced harms), and new
potential harms can be enumerated through systematic processes: situations that
could conceivably lead to harms are identified (e.g., for gene drive approaches for
African malaria vectors, Roberts et al. 2017; Teem et al. 2019), and the chain of
events from the decision to potential harms is articulated. The next step in risk
assessment is the evaluation of the likelihoods of each potential harm (including
different types and magnitudes of consequences for a given type of harm); this
evaluation can be qualitative or quantitative (e.g., Rausand 2011). When there is a
lack of relevant experience to inform the likelihoods (such as for potential harms
that have never occurred), the likelihood of a potential harm can be inferred from
the likelihoods of the events on the causal pathway to that harm: often there are data
to inform the likelihoods of individual events even when the full pathway is unprecedented (e.g., Hayes et al. 2018a). For example, in fault tree analysis the events on
the causal pathway to a harm are identified along with their logical relationships;
when the probabilities of the individual events are estimated, they can be combined
into an estimate of the probability of harm. The estimated likelihoods of harm have
uncertainties, which can additionally be characterized, including quantitatively
(e.g., Kaplan and Garrick 1981). Risk assessment conducted in this manner can also
inform further research on gene drive approaches: by characterizing the expected
likelihoods of harms and the uncertainties associated with those expectations,
research studies and monitoring plans can be developed to prioritize reduction of
the most consequential uncertainties.
Structured risk assessment methods have been applied across a range of complex
systems, including to living modified organisms (e.g., Hayes et al. 2018a). Risk
assessment is a component of many regulatory frameworks, and in particular ecological risk assessment is used by many environmental authorities (e.g., US EPA
2019; EFSA n.d.) and specifically recommended for the evaluation of gene drive
approaches (NASEM 2016). The Cartagena Protocol on Biosafety requires “case-by-
case,” “scientifically sound” risk assessment for international transboundary movement of living modified organisms intended for use in the environment (Secretariat
of the CBD 2000). No genetically engineered gene drive approach has advanced to
the stage of risk assessment, but independent probabilistic risk assessments have
been released for the contained use and small-scale field release of a genetically
sterile malaria vector in Burkina Faso (Hayes et al. 2015, 2018b), demonstrating
methods that could be applied to risk assessments of gene drive approaches.

Governing Gene Drive Approaches That Could Cross Borders
Similar to gene drive approaches, many environmental decisions have implications
beyond the area in which they are implemented, and there are frameworks and institutions to support those decisions. Of particular relevance are decisions in a country
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that can affect other countries, such as use of water from a shared source (e.g.,
General Assembly of the United Nations 1997). International governance institutions such as regional organizations (e.g., the European Union, the African Union)
and the United Nations provide platforms for international treaties and agreements,
which can inform national laws and policies. Specifically, international institutions
exist to support decision making on living modified organisms (e.g., the Cartagena
Protocol on Biosafety) and potential applications of gene drive approaches such as
public health (e.g., the World Health Organization) and biodiversity conservation
(e.g., the Convention on Biological Diversity). These institutions provide binding
requirements and guidance to participating countries that apply to gene drive
approaches, including provisions for liability and redress in cases where a living
modified organism used within a country moves to another country and causes harm
(e.g., the Nagoya-Kuala Lumpur Supplementary Protocol; Secretariat of the CBD
2011). Regional institutions can also provide guidance on the development of
regional regulatory frameworks and capacity (e.g., in the African Union, Glover
et al. 2018, and specifically for gene drive approaches for malaria, African Biosafety
Network of Expertise 2018).

Effectively Engaging Communities in Decisions
Although community engagement is expected to be challenging for research and
use of gene drive approaches, there are examples to learn from and frameworks
to guide future efforts. For example, foundational features of the community
engagement approach of the Eliminate Dengue/World Mosquito Program have
been functionally related to their impact, which may be informative for other
approaches (Kolopack et al. 2015). There are relevant engagement frameworks
that have been developed for genetically modified mosquitoes (e.g., Lavery et al.
2010; World Health Organization 2014; Thizy et al. 2019; Singh 2019), mice that
carry tick-borne pathogens (Buchthal et al. 2019), and biodiversity (e.g., Rask
and Worthington 2015). The Cartagena Protocol on Biosafety requires its signatories to promote public awareness, understanding, and participation in the decision-making process for living modified organisms (which many possible gene
drive approaches would be categorized within), and there is an ongoing program
of work within the Protocol to advance priority areas (UN Environment
Programme 2016).
In summary, these frameworks highlight the importance of “an expansive
notion of ‘engagement’” (Bartumeus et al. 2019). Identifying communities,
stakeholders, and publics for engagement, accounting for the uncertainties associated with spread and persistence, needs to be continuous because those identifications are likely to evolve (NASEM 2016). Engagement early and throughout
the research process provides transparency and enables co-creation of approaches
(e.g., Esvelt 2017; Hartley et al. 2019). Communication should use language
appropriate to different audiences so that messages are understandable (e.g.,
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Quinlan et al. 2016). Finally, a common refrain is the importance of financial
resources and human capacity dedicated to community engagement, for research
(e.g., King et al. 2014) and in government decisions (UN Environment
Programme 2016).

Conclusion
Collectively, the existing appropriate frameworks, processes, and institutions provide a context to address the challenges of evaluating gene drive approaches for public
benefit. Established methods can characterize the expectations and uncertainties for
research and use of a gene drive approach, such as the range of areas and communities
that may be affected. Institutions exist to use that information to make decisions
given their responsibilities and processes, and national and international governance
enables decision making across communities beyond those in which a gene drive
approach is introduced. Community engagement will need to be tailored for each
individual case, but past experience and conceptual frameworks can guide these
important activities. The next section closes with important considerations for the
effective application of this context to evaluate gene drive approaches for public
benefit.

 ecommendations on Decision Making for Gene
R
Drive Approaches
Having identified the context that can help address the challenges to evaluating gene
drive approaches, the effective application of that context requires resources to
implement risk assessment, support research, and engage communities; diligent
implementation by governance institutions; and the continued evolution of the
frameworks, processes, and institutions.
Rigorous evaluation of gene drive approaches may be resource intensive, similar
to other regulatory decisions, and appropriate regulatory capacity is required. Some
governance institutions may already possess sufficient capacity, and in other cases
capacity strengthening may be a necessary precursor to evaluation of gene drive
approaches. International organizations can and should play an important role in
supporting capacity development (e.g., Glover et al. 2018).
Research is an important tool to inform the potential benefits, costs, harms, and
likelihoods of different outcomes from the use of a gene drive approach. Baseline
environmental studies can help characterize population biology and ecosystem relationships (e.g., Moro et al. 2018) and contained use studies may reduce other uncertainties (e.g., Hayes et al. 2018a). Mathematical modeling can provide insights into
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potential outcomes of research or use of gene drive approaches over a range of
potential contexts (e.g., Sánchez et al. 2019). Ethical, legal, and social science
research will continue to inform fair and effective approaches for making decisions
(e.g., National Research Council 2005; NASEM 2016). It is important that these
research areas receive sufficient funding to provide informative input into the evaluation of gene drive approaches.
Decisions about gene drive approaches for public benefit, like other important public decisions, should be made with diligence, rigor, and transparency, with the understanding that a just process will produce decisions that are unlikely to satisfy every
stakeholder. It is a role of governments to fairly represent the values of their constituencies in decision making, recognizing that even in processes widely recognized as
good governance, such as free and fair elections, a large minority of constituents may
disagree with the decision (e.g., UN General Assembly 1966). In addition, some gene
drive approaches may have the potential to spread across national boundaries, requiring national authorities to act on their international obligations.
The frameworks, processes, and institutions that exist to address the challenges
of evaluating gene drive approaches should continuously improve the support they
provide for decision making. Given the limited current experience with gene drive
approaches, it will be valuable to continue to refine the methods for identifying and
characterizing potential outcomes. Governance at the national level evolves, and
regular convenings of international institutions provide venues to further interpret
treaties and agreements and develop guidance. Community engagement methods
will continue to be informed by experience from research and governance of gene
drive approaches and analogous domains. Progress in these areas, including on
international liability and redress, is a necessary complement to technical progress
on gene drive approaches (e.g., Oye et al. 2014). For example, the Ad Hoc Technical
Expert Group on Risk Assessment of the Cartagena Protocol on Biosafety is specifically tasked with informing decisions on whether additional guidance for risk
assessment of genetically engineered gene drive approaches is necessary (UN
Environment Programme 2018).
Gene drive approaches have the potential to provide important public benefits by
making changes in the natural environment. Evaluating them will be challenging for
decision makers: ecosystems are complex, governing changes that can affect multiple communities is complicated, and there is limited experience with the use of
gene drive approaches. However, these challenges are not confronted in a void.
Because making decisions about the shared environment under conditions of uncertainty is a common responsibility across many domains, there are existing frameworks, processes, and institutions that can help address these challenges. If the
appropriate resources and diligence are applied, it will be possible to responsibly
evaluate and make decisions on gene drive approaches for public benefit.
Acknowledgments I gratefully acknowledge thoughtful input on this contribution from four
anonymous reviewers, colleagues at the Foundation for the National Institutes of Health, Western
Michigan University, EHS Consultancy, and the Commonwealth Scientific and Industrial Research
Organisation.
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